QHM-2025-9854 Wigton Group Medical Practice- Local Enhanced Service

The NHS North East and North Cumbria Integrated Care Board is set to finalise a contract under the Direct Award Process A as per the Health Care Services (Provider Selection Regime) regulations 2023. The contract, titled "QHM-2025-9854 Wigton Group Medical Practice- Local Enhanced Service," pertains to the health services industry category and involves services such as Near Patient Testing, Warfarin Monitoring, and Hormonal Injection Administration. This procurement, located in the UKC region (Sunderland), was completed with an award date on 1st October 2025.

The contract covers services starting from 1st April 2025 to 31st March 2026, although services had been delivered under an implied contract previously. This tender process is at the Award stage and operates under a 'limited' procurement method, allowing a contract to be awarded without the prior publication of a call for competition. This procurement presents significant opportunities for businesses operating in health services, especially those specialising in local enhanced services like medical practice management and drug monitoring.

It is particularly suited to large-scale medical providers like Wigton Group Medical Practice, which was awarded the contract given there were no viable alternative providers. Although the contract value is activity-based with no guaranteed amount, businesses experienced in flexible service delivery and possessing the capability for high-quality care can thrive. This opportunity allows businesses to expand their expertise in public sector healthcare contracts and maintain valuable relationships with NHS authorities.